|Organiser||European School of Urology|
|Duration||Approx. 60 minutes|
Lectures will highlight the first-line and second-line treatment in this stage of the disease. The last part of the e-course will focus on the clinical management of adverse events following systemic treatment in metastatic RCC.
CME: This e-course is accredited with 1 European CME credit (ECMEC®) upon completion.
This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.
Contact our organiser
European School of Urology